Angiotensin Converting Enzyme inhibitor or Angiotensin Receptor Blocker (if intolerant of Angiotensin Converting Enzyme inhibitor) in diabetes with evidence of renal disease, i.e., dipstick proteinuria or microalbuminuria (>30 mg/24 hours) with or without serum biochemical renal impairment. Here, ACE is linked to kidney disorder.